Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
05/2008
05/29/2008WO2008062469A2 Selective tr-beta 1 agonist
05/29/2008WO2008062460A2 Crystalline forms of pregabalin
05/29/2008WO2008061954A1 Novel co-initiators
05/29/2008WO2008061270A1 Novel method for producing 4,4'-(1-methyl-1,2-ethanediyl)-bis-(2,6-piperazinedione)
05/29/2008US20080125603 Lithium bicarbonate, lithium carbonate cocatalyst modifies NaY faujasite zeolite; selective mono-N-alkylation of only one amino group in aromatic diamines; valuable intermediates for the preparation of dyes
05/29/2008US20080125601 Key steps in the synthesis are early introduction of the correct absolute stereochemistry at C-3 (R) and subsequent regioselective chain lengthening; Unlike the linear synthesis processes in the prior art, the use of the novel statin side chain building blocks allows a convergent synthesis
05/29/2008US20080125483 3-Aminomethyl-5-methyl-hexanoic acid 1-ethyloxycarbonyloxy-ethyl ester; epilepsy, depression, anxiety, psychosis, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, panic, pain
05/29/2008US20080124285 Merocyanine Derivatives for Cosmetic Use
05/29/2008CA2670282A1 A new method for preparing 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
05/28/2008EP1925609A1 Novel-co-initiators
05/28/2008EP1924548A2 Ester prodrugs of prostratin and related phorbol compounds
05/28/2008EP1322595B1 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
05/28/2008CN101186583A Methyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate and its synthesizing method and application
05/28/2008CN101186582A Method for separating and purifying phenylalanine from phenylalanine fermentation liquor
05/28/2008CN101186581A Continuous clean synthesis method for sodium iminodiacetate
05/28/2008CN101186580A Gaba analogs and its medical compositions
05/28/2008CN100390261C Compositions comprising photo-labile perfume delivery systems
05/28/2008CN100390160C Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
05/28/2008CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties
05/27/2008US7378548 Michael addition of an acrylic acid ester to a secondary amine such as diethanolamine; additives in chemical amplification photolithography giving photoresists with high resolution and excellent focus margin
05/27/2008US7378546 Method for producing 2-amino-5-iodobenzoic acid
05/27/2008US7378545 Constant stirring while heating solution of tyrosine or levothyroxine above the nucleation temperature, controlled cooling, sonication, harvesting; reduced particle size allows improved dissolution, particle uniformity and bioavailability
05/27/2008US7378446 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs
05/27/2008US7378412 Pharmaceutical compounds
05/22/2008WO2008059299A1 CHIRAL CYCLIC ß-AMINO ACIDS AND THEIR DERIVATES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF SUCH COMPOUNDS
05/22/2008WO2008020007A3 Process for the preparation of 5-hydroxyisoxazolidines, 5-isoxazolidinones, b-amino acids, b-amino aldehydes and derivatives thereof
05/22/2008US20080119659 Fluorinated bis (phthalic anhydride) and method for producing the same
05/22/2008US20080119539 Therapeutic amides
05/22/2008US20080119538 Therapeutic compounds
05/22/2008US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract
05/21/2008EP1923382A1 [18F] labelled L-glutamic acid, [18F] labelled glutamine, their derivatives, their use and processes for their preparation
05/21/2008EP1603558B1 Process for preparation of perindopril and salts thereof
05/21/2008EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/21/2008CN101182297A Method for further reclamation of L-tyrosine from effluent of L-cystine production
05/20/2008US7375248 Inhibitors of matrix metalloproteinase
05/20/2008US7375245 chemical intermediates for synthesis of angiotensin converting enzyme inhibitors, used as hypotensive agents
05/20/2008US7375243 Method for preparation of amino acid chelate
05/20/2008US7375241 use of the metal complexes as catalysts for enantioselective addition reactions with prochiral organic compounds
05/20/2008US7374749 Amino substituted hydroxyphenyl benzophenone derivatives
05/15/2008WO2008056768A1 Metal catalyst carrying carbon/ethylenediamine composites and process for production thereof
05/15/2008WO2007121312A3 Trivalent chromium compounds, compositions and methods of use
05/15/2008US20080114175 Processes and Intermediates Preparing Cysteine Protease Inhibitors
05/15/2008US20080114068 HIV antiviral agents; 2-((p-carboxyphenyl)aminocarbonylmethoxy)-5-halo-benzophenone compounds
05/15/2008US20080114064 Tri(Hydroxymethyl)Methylamine Salt or an Ethanol Amine Salt of (2S)-2-Ethoxy-3-(4-PHENYL) Propanoic Acid
05/15/2008US20080114002 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid
05/15/2008US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins
05/14/2008EP1919856A2 Process for the preparation of gabapentin
05/14/2008CN101180265A Method for asymmetric alkynylation of alpha-imino esters
05/14/2008CN100387580C Tricyclic triazolobenzazepine, derivatives, process for producing the same, and antiallergic
05/14/2008CN100387576C Substituted phenylalkanoic acid derivatives and use thereof
05/14/2008CN100387571C Process for synthesizing 2-(4'-amino benzoyl) benzoic acid
05/13/2008US7371897 Preparation method for (Z)-7-chloro-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid
05/13/2008US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
05/13/2008US7371888 α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
05/13/2008US7371854 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
05/13/2008US7371831 Azo dyestuffs
05/08/2008WO2008053331A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar).
05/08/2008WO2008052788A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
05/08/2008WO2008031567B1 Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of nep inhibitors
05/08/2008WO2007136607A3 Substituted esters as cannabinoid-1 receptor modulators
05/08/2008US20080108840 Useful for inhibiting the aggregation of amyloid protein to form amyloid deposit
05/08/2008US20080108701 Diagnostic Agent for Tumor
05/08/2008US20080108606 Side effect reduction; antiproliferative agents; schizophrenia
05/08/2008CA2667395A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, their derivatives and their use and processes for their preparation
05/08/2008CA2667211A1 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar)
05/07/2008EP1918275A1 Production method of diphenylalanine - NI(II) complex
05/07/2008EP1917234A1 Tritylation reactions based on metallic catalysis
05/07/2008EP1694630B1 Method for producing chiral or enantiomer-enriched beta-amino acids, -aldehydes, -ketones and gamma-amino alcohols
05/07/2008EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
05/07/2008EP1397372B1 Water-soluble polymeric metal ion affinity compositions and methods for using the same
05/07/2008EP1309562B1 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
05/07/2008EP1284957B1 Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine
05/07/2008CN101172956A Monomer zincium lysine, preparation and use of zincium lysine complex compound
05/07/2008CN101172955A Diamine anti-cancer medicine
05/07/2008CN101172952A Integrate chemical processes for industrial utilization of seed oils
05/06/2008US7368592 Process for the preparation of alkyl n-alkylanthranilate
05/01/2008US20080103200 Levodopa prodrugs, and compositions and uses thereof
04/2008
04/30/2008EP1916234A1 Cyclopropanecarboxylic acid compound
04/30/2008EP1506168B1 Gelling agents
04/30/2008CN101171229A Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
04/30/2008CN101171228A Pregabalin free of isobutylglutaric acid and a process for preparation thereof
04/30/2008CN101171227A Pregabalin free of lactam and a process for preparation thereof
04/30/2008CN101171226A Method for producing methylglycine-N,N-diethanoic acid-trialkali metal salts with a low by-product content
04/30/2008CN101171225A Method for the preparation of pregabalin and salts thereof
04/30/2008CN101168516A Method for extracting gamma-glutamic acid
04/30/2008CN101168515A Technique for utilizing glutamic acid production waste liquid
04/30/2008CN101168514A Practical synthesis method for alpha-aminosuberate and alpha-amino suberic acid monoester with optical activity
04/30/2008CN101168513A Method for preparing DL-serine
04/30/2008CN101168512A Method for separating and purifying valine from valine liquid
04/30/2008CN100384889C Polymerization of olefins
04/29/2008US7365230 Cross-linkable polymers and electronic devices made with such polymers
04/29/2008US7365227 Process for the preparation of gabapentin
04/29/2008US7365226 Passage of a salt of gabapentin through a ionic exchange resin of strong cationic type and elution by a mineral acid such as anaqueous solution of ammonia and sodium hydroxide
04/29/2008US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
04/29/2008US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
04/29/2008US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
04/29/2008US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
04/29/2008CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives
04/29/2008CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders
04/24/2008WO2008047376A1 An improved process for the preparation of cephalosporin antibiotic
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 215